Literature DB >> 12760398

Regression of hepatic fibrosis and cirrhosis in patients with chronic hepatitis C treated with interferon-based therapy.

Mohammed A Metwally, Claudia O Zein, Nizar N Zein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12760398     DOI： 10.1016/s0016-5085(03)00352-4

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  Sustained virologic response to peginterferon alpha-2a and ribavirin in 335 patients with chronic hepatitis C: a tertiary care center experience.

Authors:  Hamad Al Ashgar; Mohammed Q Khan; Ahmed Helmy; Khalid Al Swat; Abdullah Al Shehri; Abdalla Al Kalbani; Musthafa Peedikayel; Khalid Al Kahtani; Mohammed Al Quaiz; Mohammed Rezeig; Ingvar Kagevi; Mohammed Al Fadda
Journal:  Saudi J Gastroenterol       Date:  2008-04       Impact factor: 2.485

Review 2.  Fibrosis Regression After Eradication of Hepatitis C Virus: From Bench to Bedside.

Authors:  Don C Rockey; Scott L Friedman
Journal:  Gastroenterology       Date:  2021-01-30       Impact factor: 22.682

3.  Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4.

Authors:  Hamad Al Ashgar; Ahmed Helmy; Mohamed Q Khan; Khalid Al Kahtani; Mohammed Al Quaiz; Mohammed Rezeig; Ingvar Kagevi; Abdullah Alshehri; Abdullah Al Kalbani; Khalid Al Swat; Salim Dahab; Naser Elkum; Mohammed Al Fadda
Journal:  Ann Saudi Med       Date:  2009 Jan-Feb       Impact factor: 1.526
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.